Innovotech reported the signing of a 5-year Material Transfer and Collaboration Agreement with a global medical device company for its InnovoSILTM- 1 silver periodate (Ag5IO6) antimicrobial compound. Under the Agreement, Innovotech will receive annual payments plus costs for new, divisional, and continuing patent applications related to the collaboration with its partner. Innovotech will supply materials and its expertise to assist in the commercial development of medical devices within the scope of the Agreement. The Agreement calls for a negotiated Commercialization Agreement at any time during its term. Meanwhile, Innovotech is free to pursue applications of InnovoSILTM-1 outside of those areas that are precluded by the Agreement's focus.